The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
The Challenge of Subgroup Analyses — Reporting without Distorting
Abstract
Subgroup analyses are an important part of the analysis of a comparative clinical trial. However, they are commonly overinterpreted14 and can lead to further research that is misguided or, worse, to suboptimal patient care.Consider a randomized, clinical trial designed to determine whether a new treatment is more effective than an established treatment and assessed with a test, based on all randomized patients, of the null hypothesis that the treatments have equal efficacy, as measured in terms of the primary end point. Then, subgroup analyses are conducted to assess whether different types of patients respond differently to the new . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, analyses of HRQoL, IBS symptoms and stool characteristics data were performed in the subgroup of those definitely constipated subjects (n = 19), as defined on the only basis of <3 stools per week; a lower significance level (P < 0.001) was applied for judging results in this subgroup, as recommended.36”
Citations
Cites
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., López-Sendón, J. L., Guneri, S., Jiang, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060898 · Cited by 609
Cornell, R. G., Wolf, F. M., Bailar, J. C., & Mosteller, F. (1989) · Journal of the American Statistical Association · doi:10.2307/2289981 · Cited by 295
Yusuf, S. (1991) · JAMA · doi:10.1001/jama.266.1.93 · Cited by 129
Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trials
Parker, A. B., & Naylor, C. D. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106610 · Cited by 57
Bailar, J. C. (1986) · Cited by 28
Cited by
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
“[48] Lagakos SW.”
BackgroundAntman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188209 · Cited by 1,562
“to provide the point estimate and 95% CI of the treatment effect in various subgroups to allow readers to see the range of possible treatment effects.(82) The writing group encourages randomization of additional patients in future trials to clarify a number of questions, such as 1) the benefits of reviparin compared w…”
BackgroundStatistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445
Self-citationPfeffer, M. A., Claggett, B., Assmann, S. F., Boineau, R., Anand, I. S., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., Gordeev, I., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013255 · Cited by 1,065
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
“However, a significant effect in one group and a nonsignificant effect in the other is not sound evidence that the effect of the marker differs by subgroup [93,94].”
Background
Metadata
- Authors
- Lagakos, S. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Lagakos, Stephen W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-20
- Volume
- 354
- Issue
- 16
- Pages
- 1667-1669
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2085477178
- Semantic Scholar
- d03b954bb3525ed19f989e831c39645293c3c984
- Cited by
- 504
- References
- 7
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 23 · 2023: 13 · 2022: 14 · 2021: 13 · 2020: 21 · 2019: 34 · 2018: 21 · 2017: 21 · 2016: 23 · 2015: 29 · 2014: 21 · 2013: 26 · 2012: 29
- FWCI
- 40.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- subgroup analysis, subgroup heterogeneity, overinterpretation, reporting bias, treatment effect heterogeneity, randomized controlled trials, primary endpoint
- MeSH terms
- Data Interpretation, Statistical, False Positive Reactions, Probability, Statistics as Topic, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Challenge of Subgroup Analyses — Reporting without Distorting. https://app.cochat.ai/papers/10.1056/nejmp068070
- The paper
- Lagakos, S. W. (2006). The Challenge of Subgroup Analyses — Reporting without Distorting. New England Journal of Medicine. https://doi.org/10.1056/nejmp068070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.